Aims and objectives Learning objectives:
In previous studies, CT (computed Tomography) scan was used to differentiate malignant from benign conditions but it could not be helpful to differentiate malignant mesothelioma from metastases. [1] In this study, details of chest CT findings in these two conditions were assessed to find out if there are any imaging clues for early differentiation.
Back ground:
A spectrum of tumors can affect the pleura of which metastatic adenocarcinoma is the commonest cause of malignant pleural disease, while malignant mesothelioma is the most common primary pleural tumor. Mesothelioma is an uncommon entity and accounts for 5-28% of all malignancies that involve the pleura. There is a strong association between exposure to asbestos fibers and mesothelioma (~ 10% risk during lifetime; 40-80% of patients have a history of asbestos exposure). Unlike other asbestos related lung diseases, it doesn't appear to be dose dependent. Not all types of asbestos are strongly implicated, with crocidolite being the main causative fiber type. Sixty to eighty percent of cases are males and it approximately occurs 20 to 35 years after exposure. Although the cytological and histological diagnoses are difficult, some specific markers can be helpful in the diagnosis of different types of malignant mesothelioma. Mesothelin is the most sensitive one among them. The prognosis is poor for all tumors types. An overall median survival is 4-12 months without treatment. Five-year survival rate in favorable patients' sub-groups may be achievable up to 45%, however even with aggressive multi-modality therapy, the overall 5-year survival rate remains poor (3-18%) with a median survival time of approximately 18 months. [3] The histological type of adenocarcinoma is the most likely one which can cause metastasis in the pleura. Lung cancer (the most prevalent), breast carcinoma, ovarian cancer, lymphoma, gastric carcinoma and invasive thymoma are among the most common primary sources that result in pleural metastases. Malignant mesothelioma and Metastatic adenocarcinoma have similar imaging patterns but different prognoses and treatments. [2] CT is the imaging technique of choice for characterizing pleural masses with respect to their location, composition, and extent. It also provides important information regarding invasion of the chest wall and the surrounding structures.
Methods and materials
Chest CT scans of 113 patients [malignant mesothelioma: 55(48%) and metastatic adenocarcinoma: 58(52%)] were retrospectively reviewed by two radiologists with consensus in Masih Daneshvari university Hospital Medical Center, Tehran, Iran between 2005 to 2010.The diagnosis of Malignant Mesothelioma and Metastatic Adenocarcinoma were made by either closed pleural biopsy, thoracoscopy or thoracotomy. The CT scans were obtained before any invasive procedure was done. Scans were made from apex to the diaphragm with a 7 mm slice thickness and 4.8-sec scan time. Scans were obtained at end-inspiratory lung volumes with the position of supine in regarded patients. Both mediastinal and parenchymal window settings were used. On CT scans, pleural thickening was defined as a pleural thickness of 10 mm or less, pleural nodules as focal pleural thickness of no more than 10-30 mm and pleural masses with diameters of 30 mm or more. The involvement of mediastinal structures was manifested as obliteration of surrounding fat planes or as direct invasion to heart, esophagus, trachea or other mediastinal organs. Invasion to vascular structures was noted when soft tissue mass surrounded more than 50% of circumferential of vascular structures. The involvement of chest wall was defined as obliteration of extra pleural fat planes, invasion to intercostal muscles, and displacement of ribs or bone destruction. Invasion to ribs was noted when there was periosteal reaction, bone erosion or complete bone destruction. The effusions were considered massive if they occupied more than half of the hemi thorax. We assessed 35 CT variables ( 
Results
History of asbestos exposure was detected in 96% of cases of malignant mesothelioma while it was only present in 45% of metastatic adenocarcinoma. CT findings which were related to malignant mesothelioma like pleural plaques and calcifications were detected in 92% and 89% of cases. The affected hemi thorax was contracted with volume reduction in 74% of patients but it was seen just in 13% of metastatic adenocarcinoma. Circumferential or lobulated pleural thickening was more frequent in malignant mesothelioma (43% and 65% respectively). Pleural plaques in contralateral lung and calcified plaques were significantly more noted in mesothelioma (56% and 89% respectively). On the other hand pulmonary mass (23%) or nodule (34%) (even solitary or multiple), interstitial reticulation and interlobular septal thickening (lymphangitic carcinomatosis) (15%), the involvement of contralateral lung with nodule or mass(68%), midline mediastinum(43%) or increased lung volume and contralateral shift of mediastinum mostly in patients with massive pleural effusions(56%), were in favor of metastatic adenocarcinoma. Invasion to chest wall and lobar fissure were more common in malignant mesothelioma (23% vs. 15%), while bony metastasis and mediastinal lymphadenopathy were more frequent in metastatic adenocarcinoma (18% vs. 12%). Invasion to mediastinal organs (46% vs 12%) and vascular structures (49% vs 11%) and diaphragm (34% vs 16%) were reported more often in metastatic adenocarcinoma than malignant mesothelioma. Pleural effusions in malignant mesothelioma were mostly loculated (65%) and unilateral (73%), in contrast to metastatic adenocarcinoma which were bilateral in major (65%). There were no significant differences in age, sex, history of smoking, clinical features of chest pain and dyspnea, other pleural variables such as size, side, and extent of pleural effusion, pericardial effusion or thickening, the presence of pneumothorax and involvement of mediastinal pleura between these two diseases. Pleural involvement was more common in lower half of the hemi thorax in both malignant mesothelioma and metastatic adenocarcinoma. The frequency of irregular pleural margin was not significantly different between these two groups.
The details of the CT criteria of these two diseases are discussed in 
Conclusion
Malignant Mesothelioma needs to be distinguished from metastatic adenocarcinoma. These pleural tumors have different treatments and prognoses. CT scan is a primary and good imaging technique that can be used in order to differentiate these two entities. CT appearance of malignant mesothelioma and metastatic adenocarcinoma is inconsistent but has also similar findings. Using a check list containing the mentioned diagnostic CT features can be helpful in differentiation between these two diseases.
We noted that pleural plaques and calcifications especially circumferential or lobulated ones were typical features of malignant mesothelioma. The most common CT findings were unilateral pleural thickening and irregular pleuropulmonary contour. Volume contraction and reduced lung volume were present in almost all patients especially in whom the lung was encased circumferentially by tumor or in whom with chest wall involvement. Thickening of pleural fissures and unilateral loculated pleural effusion were more frequent in malignant mesothelioma. Chest wall invasion was more prevalent in this disease. These results are in agreement with those of Ahmet Altay Sahin et al. [5] CT evidence of Metastatic adenocarcinoma, such as pulmonary mass or nodule, interlobular septal thickening, bilateral pleural effusion and contralateral mediastinal shift, mediastinal lymphadenopathy, invasion to mediastinal organs, vascular structures or diaphragm , were the most common findings in our patients.
In conclusion, our results indicate that Malignant Mesothelioma and Metastatic adenocarcinoma vary in the CT findings. Although some findings are quite characteristic, none is pathognomonic. Radiologists can diagnose these two diseases to somehow by means of CT criteria but cannot definitely differentiate these two entities. 
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